|
Oct 7
|
Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
|
|
Oct 7
|
Millions urged to delete data from mail-order DNA test maker
|
|
Aug 30
|
Why Is Glaxo (GSK) Up 10.3% Since Last Earnings Report?
|
|
Aug 28
|
GSK plc (GSK): A Cheap Pharmaceutical Stock to Buy According to Short Sellers
|
|
Aug 28
|
Five alternatives to Mag 7 stocks if you missed out on Nvidia
|
|
Aug 28
|
GSK shares rise on Delaware Supreme Court appeal in Zantac case
|
|
Jul 24
|
GSK (GSK) Earnings Expected to Grow: Should You Buy?
|
|
Jun 16
|
The $3bn crisis casting a shadow over Dame Emma Walmsley’s GSK
|
|
Jun 16
|
The heartburn drug giving British pharma giant GSK a $3bn headache
|
|
May 15
|
GSK PLC's Dividend Analysis
|
|
May 11
|
GSK plc (LON:GSK) Stock Goes Ex-Dividend In Just Four Days
|
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|
|
Mar 28
|
GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know
|
|
Mar 28
|
UPDATE 1-U.S. FDA approves Akebia's anemia drug
|
|
Jan 9
|
Stocks to Watch Tuesday: Boeing, Match, HPE, JetBlue
|
|
Jan 9
|
Health Care Roundup: Market Talk
|
|
Jan 9
|
FTSE 100 LIVE: Hays shares slide after 'difficult December', GSK in $1bn respiratory drug deal
|
|
Jan 9
|
GSK to buy asthma treatment firm Aiolos Bio in £1.1bn deal
|
|
Jan 9
|
GSK strikes £1.1bn deal for asthma drugmaker
|
|
Jan 9
|
GSK Enters Agreement to Acquire Aiolos Bio
|